Eyestem Presents Landmark Phase 1 Results of Eyecyte-RPE™ Trial at Innoxbio CGT 2025
Eyestem Presents Landmark Phase 1 Results of Eyecyte-RPE™ Trial at Innoxbio CGT 2025
Read moreEyestem Presents Landmark Phase 1 Results of Eyecyte-RPE™ Trial at Innoxbio CGT 2025
Read moreBENGALURU: NKure Therapeutics Private Limited, a Bengaluru-based biotech innovator, and CRISPR Therapeutics (Nasdaq: CRSP), a global leader in gene-based medicines, today announced a strategic partnership to co-develop and commercialize CTX112™,…
Read more